The efficacy and safety of micropulse transscleral cyclophotocoagulation in the treatment of glaucoma: a systematic review and meta-analysis

Ling, Qiying; Zhang, Xinyue; Duan, Xuanchu

doi:10.37766/inplasy2022.9.0120

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…69 The more common complications, such as mydriasis, AC inflammation, hypotony, and pain, can also often be managed conservatively. 70 Given its favorable safety profile, MP-TLT was studied in eyes with good visual acuity (VA). In a retrospective study of 76 eyes with refractory glaucoma and good best-corrected VA (20/60-20/20), 88.6% and 87.5% had unchanged or improved VA after a 240 and 160-second treatment, respectively.…”

Section: Micropulse Transscleral Laser Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Minimally Invasive Glaucoma Surgery: Latest Developments and Future Challenges

Chan,

Larson,

Dickerson

et al. 2023

Asia-Pacific Journal of Ophthalmology

View full text Add to dashboard Cite

The development of minimally invasive glaucoma surgeries (MIGSs) was intended to provide safe and modestly efficacious modalities for early intervention of mild-to-moderate glaucoma, with minimal trauma and rapid recovery. They were mainly ab interno procedures that reduce intraocular pressure by facilitating the aqueous outflow by bypassing the trabecular meshwork resistance, reinforcing the uveoscleral flow via the supraciliary space, and reducing aqueous production by the ciliary body. While the cumulating evidence helps shape the role of the available MIGS, the exponential new development and advancement in this field has expanded the territory of MIGS. Apart from developing subconjunctival MIGS filtration devices (Xen gel stent and PRESERFLO MicroShunt), there is a tendency to revisit the “traditional” MIGS for alternative use and to modify the procedures with consideration of the fundamental aqueous outflow physiology. Combined MIGS has also been suggested, based on the theory that their different mechanisms may provide additive or synergistic effects. The advancement of laser procedures is also promising and could supplement unmet needs along the glaucoma treatment algorithm. This review examines the broad array of MIGS, updates the recent findings, discusses their potential alternative applications, and explores future challenges.

show abstract

Section: Micropulse Transscleral Laser Treatmentmentioning

confidence: 99%

“…Compared with CW-TSCPC, MP-TLT has a similar 12-month efficacy (87.5% vs 88.6%) but with lower energy, less collateral damage, pain, and inflammation 69 . The more common complications, such as mydriasis, AC inflammation, hypotony, and pain, can also often be managed conservatively 70 …”

Section: Treatment Of the Ciliary Body For Intraocular Pressure Controlmentioning

confidence: 99%